Sleep attacks may not be a side effect of dopaminergic medication (multiple letters)

Movement Disorders

Volumn 18, Issue 12, 2003, Pages 1569-1570

  Homann, Carl Nikolaus ^a   Homann, Barbara ^b   Ott, Erwin ^c   Park, Kwang B ^d   Paus, S ^e   Brecht, H M ^f   Klockgether, T ^e   Wullner U ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b RehaResearch   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d Chungbuk National University   (South Korea)

^e UNIVERSITY OF BONN   (Germany)

^f BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CYTOCHROME C OXIDASE; CYTOCHROME P450; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LISURIDE; SEROTONIN TRANSPORTER;

AGED; CASE REPORT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DRUG HALF LIFE; DRUG METABOLISM; DRUG USE; DRUG WITHDRAWAL; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; INTERVIEW; LETTER; MALE; MEDICAL RESEARCH; MONOTHERAPY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; SHY DRAGER SYNDROME; SLEEP DISORDER; SNORING; SOCIAL ASPECT; SOMNOLENCE;

EID: 0347031301     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10612     Document Type: Letter

References (0)